Journal
EMBO MOLECULAR MEDICINE
Volume 4, Issue 12, Pages 1234-1243Publisher
WILEY
DOI: 10.1002/emmm.201201375
Keywords
clinical trials; complement; interventions; mediators; sepsis
Categories
Funding
- National Institutes of Health [GM-29507, GM-61656]
Ask authors/readers for more resources
Models of sepsis have been instructive in understanding the sequence of events in animals and, to an extent, in humans with sepsis. Events developing early in sepsis suggest that a hyperinflammatory state exists, accompanied by a buildup of oxidants in tissues reflective of a redox imbalance. Development of immunosuppression and degraded innate and adaptive immune responses are well-established complications of sepsis. In addition, there is robust activation of the complement system, which contributes to the harmful effects of sepsis. These events appear to be associated with development of multiorgan failure. The relevance of animal models of sepsis to human sepsis and the failure of human clinical trials are discussed, together with suggestions as to how clinical trial design might be improved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available